Get started

Centro de Tratamiento e investigación sobre cáncer Luis Carlos Sarmiento Angulo

Alternate name: Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC)
ROR: 01524r080
OpenAlex ID: I4405264160
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
2024 · Fatima Cardoso, Shani Paluch-Shimon, et al. · The Breast · 239
Effectiveness of diaphragmatic ultrasound as a predictor of successful weaning from mechanical ventilation: a systematic review and meta-analysis
2023 · Henry M. Parada-Gereda, Adriana L. Tibaduiza, et al. · Critical Care · 123
PDF
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
2022 · Diego de Miguel-Perez, Alessandro Russo, et al. · Journal of Experimental & Clinical Cancer Research · 117
PDF
Tackling Osimertinib Resistance in EGFR-Mutant Non–Small Cell Lung Cancer
2023 · Juan Bautista Blaquier, Sandra Ortiz-Cuaran, et al. · Clinical Cancer Research · 81
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study
2023 · Do‐Youn Oh, Alain Algazi, et al. · Cancer · 64
PDF
Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
2021 · Juan Bautista Blaquier, Andrés Felipe Cardona, et al. · Frontiers in Oncology · 58
PDF
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations
2022 · Christian Caglevic, Christian Rolfo, et al. · JCO Global Oncology · 53
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study
2026 · Nicoletta Colombo, Emese Zsiros, et al. · The Lancet · 48
Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer
2022 · Diego de Miguel‐Perez, Alessandro Russo, et al. · Cancer · 46
PDF
Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question
2022 · Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, et al. · Pharmaceutics · 39
PDF
STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP)
2022 · Vladmir C. Cordeiro de Lima, Marcelo Corassa, et al. · Lung Cancer · 38
Sentinel lymph node detection in early-stage ovarian cancer: a systematic review and meta-analysis
2023 · Nuria Agusti, David Viveros-Carreño, et al. · International Journal of Gynecological Cancer · 34
PDF
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC
2023 · Luis Lara-Mejía, Andres F. Cardona, et al. · Journal of Thoracic Oncology · 32
PDF
Diagnostic accuracy of sentinel lymph node frozen section analysis in patients with early-stage cervical cancer: A systematic review and meta-analysis
2023 · Nuria Agustí, David Viveros-Carreño, et al. · Gynecologic Oncology · 30
Testicular cancer
2025 · Julian Chavarriaga, Lucia Nappi, et al. · The Lancet · 29
Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial
2024 · Silvia Allende, Jenny G Turcott, et al. · The Oncologist · 29
Engineering the next generation of CAR T- cells: precision modifications, logic gates and universal strategies to overcome exhaustion and tumor resistance
2026 · Juan Esteban Garcia-Robledo, Sergio Cabrera-Salcedo, et al. · Frontiers in Oncology · 27
PDF
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer
2023 · Diego de Miguel-Perez, Francisco Gabriel Ortega, et al. · Biomarker Research · 23
PDF
Fragmentation of Care and Its Association With Survival and Costs for Patients With Breast Cancer in Colombia
2023 · Óscar Gamboa, Giancarlo Buitrago, et al. · JCO Global Oncology · 23
PDF
Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma
2022 · Oscar Arrieta, Zyanya Lucia Zatarain-Barrón, et al. · JAMA Oncology · 23
Integration of artificial intelligence and precision oncology in Latin America
2022 · Liliana Sussman, Juan Esteban Garcia-Robledo, et al. · Frontiers in Medical Technology · 22
PDF
Hacia una mejor predicción de la mortalidad en pacientes oncológicos en UCI: análisis comparativo de escalas pronósticas: revisión sistemática de la literatura
2024 · Andrea Cabrera Losada, Maria Alejandra Correa Oviedo, et al. · Medicina Intensiva · 21
DICER1-associated central nervous system sarcoma: A comprehensive clinical and genomic characterization of case series of young adult patients
2023 · Andrés F Cardona, Diego Fernando Chamorro Ortiz, et al. · Neuro-Oncology Practice · 21
PDF
Surgical Deescalation Within Gynecologic Oncology
2025 · Alexa Kanbergs, Alexander Melamed, et al. · JAMA Network Open · 20
PDF
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study
2023 · Diego F. Chamorro, Andrés F. Cardona, et al. · Targeted Oncology · 20
PDF
Works count: 438
Citation count: 2,710
Year
Topic
Type